W.R. Berkley Corporation 4.25%
W.R. Berkley Corporation 4.25% (WRB-PG) Financial Performance & Income Statement Overview
Review W.R. Berkley Corporation 4.25% (WRB-PG) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
W.R. Berkley Corporation 4.25% (WRB-PG) Income Statement & Financial Overview
Access detailed annual and quarterly income data for W.R. Berkley Corporation 4.25% WRB-PG financial performance.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $3.55B | $3.67B | $3.40B | $3.31B |
Cost of Revenue | $2.76B | $2.74B | $2.68B | $2.62B |
Gross Profit | $785.12M | $925.98M | $717.26M | $698.36M |
Gross Profit Ratio | $0.22 | $0.25 | $0.21 | $0.21 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Expenses | $246.51M | $197.68M | $242.81M | $210.68M |
Total Costs & Expenses | $3.009B | $2.94B | $2.93B | $2.83B |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $31.73M | $31.75M | $31.72M | $31.71M |
Depreciation & Amortization | -$9.79M | -$13.64M | -$11.93M | -$64.28M |
EBITDA | $560.55M | $746.41M | $494.24M | $455.10M |
EBITDA Ratio | $0.16 | $0.20 | $0.15 | $0.14 |
Operating Income | $538.61M | $728.30M | $474.45M | $487.67M |
Operating Income Ratio | $0.15 | $0.20 | $0.14 | $0.15 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
Income Before Tax | $538.61M | $728.30M | $474.45M | $487.67M |
Income Before Tax Ratio | $0.15 | $0.20 | $0.14 | $0.15 |
Income Tax Expense | $121.26M | $152.96M | $109.14M | $115.79M |
Net Income | $417.57M | $576.10M | $365.63M | $371.91M |
Net Income Ratio | $0.12 | $0.16 | $0.11 | $0.11 |
EPS | $1.05 | $1.45 | $0.92 | $0.93 |
Diluted EPS | $1.04 | $1.44 | $0.91 | $0.92 |
Weighted Avg Shares Outstanding | $396.93M | $398.04M | $398.34M | $400.27M |
Weighted Avg Shares Outstanding (Diluted) | $399.82M | $400.89M | $401.82M | $403.74M |
The company's financials show resilient growth, with revenue advancing from $3.31B in Q2 2024 to $3.55B in Q1 2025. Gross profit remained healthy with margins at 22% in Q1 2025 compared to 21% in Q2 2024. Operating income hit $538.61M last quarter, sustaining a consistent 15% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $560.55M. Net income dropped to $417.57M, while earnings per share reached $1.05. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan